Lessee, Operating Lease, Liability, to be Paid in USD of NKGen Biotech, Inc. from Q3 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
NKGen Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q3 2023 to Q4 2024.
  • NKGen Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $491K, a 32.4% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $491K -$235K -32.4% 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $550K +$450K +450% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $608K 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $667K 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $726K 31 Dec 2023 10-K 16 Apr 2024
Q3 2023 $100K 30 Sep 2023 10-Q 14 Nov 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.